Skip to main content
Clinical Trials/JPRN-UMIN000006963
JPRN-UMIN000006963Completed未知

The effect of intervention with darbepoetin alfa on progression of renal decline[chronic renal failure?] in renal anaemia patients with chronic kidney disease not on dialysis. - Renal function is sustained by renal anemia inprovement using Nesp.- Juntendo (REFRAIN -J study)

Division of Nephrology,Department of Internal Medicine,Juntendo University Faculty of Medicine0 sites200 target enrollmentStarted: December 27, 2011Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
200

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • *Patient without renal anemia *Patient having hypersensitivity to rHuEPO. *Level of Hb is more than 13g/dL *Patients with anemia caused by conditions other than renal anemia such as GI bleeding and blood desease *Patients with serious allergies or serious drug sensitivities *Patients with severe complications *Pregnant or possibly pregnant and lactaing women *Ineligible patients according to the investigator's judgment

Investigators

Sponsor
Division of Nephrology,Department of Internal Medicine,Juntendo University Faculty of Medicine

Similar Trials